Category Archives: Latest News
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD).
TMS Condensed! Rapid Acting With Improved Remission Rates With SAINT
Richard A. Bermudes, M.D. Read Full Story Here Potentiating current antidepressant treatment is much needed. Based on animal studies, caffeine may augment the effects of currently available antidepressants. Here, we tested whether habitual caffeine consumption moderates the antidepressant effects of…
FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major Depression
Nolan R. Williams, M.D. Read Full Story Here On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach for major depressive disorder pioneered by Nolan Williams, M.D., of Stanford University,…
The Implications of COVID-19 for Mental Health and Substance Abuse
The COVID-19 pandemic and the resulting economic recession have negatively affected many people’s mental health.
What Does the Future of the Mental Health Pandemic Hold?
Health experts across the country agree: we are in the midst of a mental health pandemic and have good reason to believe that this mental health crisis will lead to increased cases of depression throughout the year.
Accelerated Intermittent Theta Burst Stimulation Treatment for Depression During COVID-19 Pandemic
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.
FDA Grants Breakthrough Designation to Transcranial Magnetic Stimulation Device for Bipolar Depression
The system uses transcranial magnetic stimulation (rTMS), a noninvasive form of neuromodulation, to stimulate areas of the brain that are underactive.
A Potentially Powerful Treatment for Refractory Depression
Repetitive transcranial magnetic stimulation (rTMS) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression since 2008.